Literature DB >> 14565926

IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis.

Catherine Weir1, Claude C A Bernard, B Thomas Bäckström.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model commonly used to investigate mechanisms involved in the activation of self-reactive T cells. Whereas auto-reactive T(h)1 cells are believed to be involved in the generation of EAE, T(h)2 cells can induce EAE in immunocompromised hosts. Since the T(h)2 cytokine IL-5 can influence the nature and severity of disease, we investigated the role of IL-5 in the EAE model. Wild-type C57BL/6J and IL-5(-/-) mice were immunized with myelin oligodendrocyte glycoprotein (MOG)(35-55) peptide and the development of EAE observed. Our results show that IL-5(-/-) mice developed EAE with a similar day of onset and comparable severity to wild-type mice. Primed T cells isolated from IL-5(-/-) mice proliferated equally to wild-type cells in response to antigen challenge with MOG(35-55). Antigen-specific T cells from IL-5(-/-) mice produced IFN-gamma and tumor necrosis factor-alpha, but no IL-4 or IL-10, indicating that a predominant T(h)1 environment was induced following immunization. No differences in the types of cells infiltrating into the central nervous system were observed between IL-5(-/-) and wild-type mice. Our results suggest that IL-5 is not directly involved in the initiation or effector phase of MOG(35-55)-induced EAE in immunocompetent C57BL/6J mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565926     DOI: 10.1093/intimm/dxg127

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

2.  Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6.

Authors:  Ji-Eun Seo; Mahbub Hasan; Joon-Seung Han; Nak-Kyoon Kim; Ji Eun Lee; Kang Mi Lee; Ju-Hyung Park; Ho Jun Kim; Junghyun Son; Jaeick Lee; Oh-Seung Kwon
Journal:  Neurochem Res       Date:  2015-10-13       Impact factor: 3.996

3.  Multiple linked quantitative trait loci within the Tmevd2/Eae3 interval control the severity of experimental allergic encephalomyelitis in DBA/2J mice.

Authors:  K M Spach; L K Case; R Noubade; C B Petersen; B McElvany; N Zalik; W F Hickey; E P Blankenhorn; C Teuscher
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

4.  Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.

Authors:  Tarik Touil; Bogoljub Ciric; Elvira Ventura; Kenneth S Shindler; Bruno Gran; Abdolmohamad Rostami
Journal:  J Neurol Sci       Date:  2008-06-10       Impact factor: 3.181

Review 5.  Immunologic pathogenesis of multiple sclerosis.

Authors:  Min-Fang Guo; Ning Ji; Cun-Gen Ma
Journal:  Neurosci Bull       Date:  2008-12       Impact factor: 5.203

6.  IL-25 regulates Th17 function in autoimmune inflammation.

Authors:  Melanie A Kleinschek; Alexander M Owyang; Barbara Joyce-Shaikh; Claire L Langrish; Yi Chen; Daniel M Gorman; Wendy M Blumenschein; Terrill McClanahan; Frank Brombacher; Stephen D Hurst; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

7.  Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells.

Authors:  Giang T Tran; Paul L Wilcox; Lindsay A Dent; Catherine M Robinson; Nicole Carter; Nirupama D Verma; Bruce M Hall; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

8.  Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.

Authors:  Matthew W Klinker; Tamra J Reed; David A Fox; Steven K Lundy
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.